Physician

John E Levine, MD

According to 2025 Medicare claims, John Levine, MD (NPI: 1720098353) practices hematopoietic cell transplantation and cellular therapy in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1750649612; TIN: 611661781) and primary practice location at 10029-6500. Levine is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Levine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 24 traditional Medicare patients, billed 142 HCPCS/CPT codes, and received $14,123 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 62 prescription claims totaling $96,009 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 31 records totaling $63,146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $14,819 and ending at $14,123. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $27,204 to $96,009. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$11K$23K2016 Medicare payment: $14,819 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $20,589 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $17,452 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $18,482 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $9,282 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $20,705 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $22,629 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $19,961 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $14,123 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201628159$14,819
201750227$20,589
201840186$17,452
201948198$18,482
20201997$9,282
202149214$20,705
202241225$22,629
202340192$19,961
202424142$14,123

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$48K$96K2015 Drug cost: $27,204 (USD; Tot_Drug_Cst)2016 Drug cost: $5,511 (USD; Tot_Drug_Cst)2020 Drug cost: $213 (USD; Tot_Drug_Cst)2022 Drug cost: $21,991 (USD; Tot_Drug_Cst)2023 Drug cost: $58,196 (USD; Tot_Drug_Cst)2024 Drug cost: $96,009 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R60$27,204
2016N/R13$5,511
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R13$213
2021N/RN/RN/R
2022N/R29$21,991
2023N/R37$58,196
2024N/R62$96,009

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes16106$103

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate11330$95,042
Duloxetine HclDuloxetine Hcl15450$424
AcyclovirAcyclovir11330$176
GabapentinGabapentin12360$63

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$24,698Incyte Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.8$38,448Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John E. Levine, MD?

Tedicare shows public-source Medicare data for John E. Levine, MD (NPI 1720098353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John E. Levine, MD have ACO affiliation data?

John E. Levine, MD is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to John E. Levine, MD?

John E. Levine, MD is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1750649612) in the available physician profile data.

Does John E. Levine, MD have Open Payments data?

John E. Levine, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.